EVIDENCE LIBRARY
Clonazepam and Sleep Behaviors in Two Sisters With Hyperekplexia
A two-sibling report described improved startles and sleep-related motor activity with clonazepam in a rare genetic disorder.
A two-sibling report described improved startles and sleep-related motor activity with clonazepam in a rare genetic disorder.
A distinctive clinical phenotype
Both sisters had a homozygous GLRA1 variant associated with hereditary hyperekplexia. Polysomnography documented non-REM startles and REM motor activity consistent with REM sleep behavior disorder. The authors described improvement in startles, motor behavior, and REM muscle activity after clonazepam.
Response does not establish a general treatment effect
Two related patients provide detailed clinical observations but no randomized comparator or reliable estimate of benefit frequency. Shared genetics and a rare phenotype also limit extension to unrelated sleep disorders. The report suggests a relationship between impaired glycinergic transmission and abnormal sleep behaviors, rather than proving a complete mechanism. In a case review, distinguish the recorded polysomnographic findings from the inference about treatment response. Improvement with clonazepam does not by itself diagnose hyperekplexia or show that every nocturnal movement disorder will respond similarly.
Source paper
Original analysis of the supplied journal article, identified as PMC6764621.